Jane Street
ENSC icon

Jane Street’s Ensysce Biosciences ENSC Stock Holding History

Jane Street’s Portfolio ENSC Stock Details ENSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60.6K Buy
208,833
+195,263
+1,439% +$70.5K ﹤0.01% 10852
2026
Q1 		$7.31K Buy
+13,570
New +$8.61K ﹤0.01% 11331
2022
Q4 		– Sell
-6
Closed -$4K – 9367
2022
Q3 		$4K Buy
+6
New +$9.78K ﹤0.01% 9467
2022
Q1 		– Sell
-5
Closed -$79K – 10451
2021
Q4 		$79K Buy
5
+2
+67% +$18.8K ﹤0.01% 9346
2021
Q3 		$38K Buy
+3
New +$58.6K ﹤0.01% 9627

Other funds holding ENSC

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
TIAM2
Tru Independence Asset Management 2 Portland, Oregon $185M AUM 20.3% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Jane Street's ENSC Position: Q2 2026 in Review

Jane Street increased its Ensysce Biosciences (ENSC) stake by 1,439% in Q2 2026, buying an estimated $70.5K and bringing the position to 208,833 shares worth $60.6K. The position accounts for ﹤0.01% of the portfolio, ranked #10852.

Jane Street first reported a position in ENSC in Q3 2021 and has held it in 5 quarters since. The position peaked at $79K in Q4 2021. 18 funds tracked by Wall St. Rank hold ENSC as of Q2 2026.

  • Jane Street held 208,833 shares of Ensysce Biosciences worth $60.6K as of Q2 2026.
  • Jane Street bought 195,263 Ensysce Biosciences shares in Q2 2026, an estimated $70.5K.
  • Ensysce Biosciences made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #10852 holding.
  • Jane Street first reported a position in Ensysce Biosciences in Q3 2021 and has held it in 5 quarters since.
  • Jane Street's Ensysce Biosciences position peaked at $79K in Q4 2021.
  • 18 funds tracked by Wall St. Rank held Ensysce Biosciences as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.